bpc 157 approved by fda is human use BPC-157 Just Cleared a Major Regulatory Hurdle If smartmedicine #bpc157 #fda #evidencebasedmedicine #orthopedics

Good options include: Pet food manufacturers sometimes add extra vitamin B12 to their diets

Patches: Skin patches deliver hormones through the skin, bypassing the liver and potentially reducing the risk of certain side effects

Compare that to 100 units at 10mg/ml concentration

Loving everything

B12 injections bypass dietary gaps and absorption challenges, making them an excellent option for individuals following plant-based diets who want to ensure optimal energy, neurological support, and mood stability

TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days